CardioTech boosts working capital:
This article was originally published in Clinica
Executive Summary
CardioTech, which is developing small bore vascular grafts and polymer-based materials, has raised $1.25 million through exercising options on 839,000 of its 1.8 million stock warrants issued in 1998. The Woburn, Massachusetts-based company said that the funds would be applied to marketing for the Vasculink vascular access graft outside the US and on further development of the MyoLink peripheral graft.